rs41279975

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001303256.3(MORC2):​c.2238A>G​(p.Glu746Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00322 in 1,614,140 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0033 ( 11 hom. )

Consequence

MORC2
NM_001303256.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.36

Publications

1 publications found
Variant links:
Genes affected
MORC2 (HGNC:23573): (MORC family CW-type zinc finger 2) This gene encodes a member of the Microrchidia (MORC) protein superfamily. The encoded protein is known to regulate the condensation of heterochromatin in response to DNA damage and play a role in repressing transcription. The protein has been found to regulate the activity of ATP citrate lyase via specific interaction with this enzyme in the cytosol of lipogenic breast cancer cells. The protein also plays a role in lipogenesis and adipocyte differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016]
MORC2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease axonal type 2Z
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 22-30934147-T-C is Benign according to our data. Variant chr22-30934147-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.36 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00223 (340/152262) while in subpopulation NFE AF = 0.00376 (256/68024). AF 95% confidence interval is 0.00338. There are 2 homozygotes in GnomAd4. There are 159 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 340 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MORC2NM_001303256.3 linkc.2238A>G p.Glu746Glu synonymous_variant Exon 20 of 26 ENST00000397641.8 NP_001290185.1 Q9Y6X9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MORC2ENST00000397641.8 linkc.2238A>G p.Glu746Glu synonymous_variant Exon 20 of 26 5 NM_001303256.3 ENSP00000380763.2 Q9Y6X9-1

Frequencies

GnomAD3 genomes
AF:
0.00223
AC:
340
AN:
152144
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000628
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00340
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00376
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00219
AC:
551
AN:
251412
AF XY:
0.00223
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00416
Gnomad NFE exome
AF:
0.00347
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00332
AC:
4853
AN:
1461878
Hom.:
11
Cov.:
32
AF XY:
0.00333
AC XY:
2419
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33480
American (AMR)
AF:
0.000537
AC:
24
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000927
AC:
80
AN:
86258
European-Finnish (FIN)
AF:
0.00380
AC:
203
AN:
53418
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00390
AC:
4342
AN:
1112004
Other (OTH)
AF:
0.00303
AC:
183
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
284
568
852
1136
1420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00223
AC:
340
AN:
152262
Hom.:
2
Cov.:
31
AF XY:
0.00214
AC XY:
159
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41552
American (AMR)
AF:
0.000654
AC:
10
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00125
AC:
6
AN:
4816
European-Finnish (FIN)
AF:
0.00340
AC:
36
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00376
AC:
256
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00280
Hom.:
0
Bravo
AF:
0.00190
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 09, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MORC2: BP4, BP7, BS1 -

Charcot-Marie-Tooth disease axonal type 2Z Benign:2
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
4.7
DANN
Benign
0.66
PhyloP100
-1.4
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41279975; hg19: chr22-31330134; COSMIC: COSV99310681; COSMIC: COSV99310681; API